Explore 3 Stock Ideas & Industry Insights Download Free Report

Monash Ivf Group Ltd

Company price
0.74 AUD 0.00(0%)
Last update at 2026-11-06T05:10:00Z
VOLUME
280548
Market Cap
288.33M
P/E
37.00

Momentum Score

…

Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.72
Low
0.74
High
52 Week Price Range
0.56
Low
0.86
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Monash IVF Group is an Australian provider of assisted reproductive services operating a network of fertility clinics, diagnostic and laboratory services primarily in Australia and New Zealand. Long-term growth may be supported by later childbearing, greater use of assisted reproductive technologies and expansion of diagnostics, and investors may find the company attractive for exposure to recurring healthcare services.

Key risks include changes to government funding and regulation of fertility services, competition and pricing pressure, and operational dependence on clinical outcomes and specialist staff that could affect demand and reputation.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.74
Dividend Yield
3.38%
Revenue TTM
269.46M
Revenue Per Share
0.69
Gross Profit TTM
76.77M
Debt / Equity
0.80
ROE
3.31%
Net Debt
190.78M
ROCE
4.63%
Diluted EPS TTM
0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 11.38M 36.12M -10.66M 29.84M 26.22M
Minority interest - - -0.58M -0.13M -0.10M
Net income 7.42M 25.01M -6.53M 21.84M 18.41M
Selling general administrative - 15.76M 88.82M 74.13M 66.88M
Selling and marketing expenses - 8.06M 7.72M 6.92M 6.43M
Gross profit 61.93M 90.31M 85.50M 191.19M 172.51M
Reconciled depreciation - - 18.58M 15.34M 14.79M
Ebit 20.68M 44.17M -7.80M 31.07M 26.65M
Ebitda 44.03M 53.01M 10.78M 46.41M 41.44M
Depreciation and amortization 23.35M 8.84M 18.58M 15.34M 14.79M
Operating income 20.68M 43.41M -5.61M 35.00M 28.37M
Other operating expenses 248.78M 228.50M 260.57M 101.04M 87.70M
Interest expense 9.20M 7.39M 5.37M 1.23M 0.43M
Tax provision - 10.45M -4.71M 7.87M 7.72M
Interest income - 7.29M 0.06M 0.03M 0.00M
Net interest income - - -5.31M -3.28M -2.15M
Income tax expense 3.06M 10.45M -4.71M 7.87M 7.72M
Total revenue 269.46M 271.92M 254.96M 213.59M 192.29M
Total operating expenses 41.26M 46.90M 91.11M 158.07M 144.14M
Cost of revenue 207.53M 181.60M 169.46M 22.40M 19.79M
Total other income expense net -9.29M -7.29M -5.05M -5.16M -2.15M
Net income from continuing ops - - -5.95M 21.97M 18.50M
Net income applicable to common shares - 25.01M -6.53M 21.84M 18.41M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 512.35M 492.61M 508.47M 421.89M 380.82M
Intangible assets 22.20M 23.88M - 25.32M 25.72M
Other current assets 7.29M 15.34M 5.68M 4.98M 4.06M
Total liab 258.88M 242.19M 261.81M 146.82M 110.92M
Total stockholder equity 249.16M 246.28M 241.91M 273.20M 267.92M
Other current liab 37.67M 45.89M 30.44M 5.71M 0.48M
Common stock 506.79M 506.79M 506.79M 506.79M 506.79M
Capital stock - - - 506.79M 506.79M
Retained earnings -162.74M -117.14M -162.74M -162.74M -162.74M
Other liab - - - 6.61M 2.65M
Good will 273.35M 273.35M 273.35M 255.13M 233.17M
Other assets - - - 0.68M 0.17M
Cash 8.84M 9.43M 11.33M 8.01M 7.87M
Cash and equivalents - - - 1.44M 0.97M
Total current liabilities 65.74M 61.41M 118.82M 46.50M 38.17M
Current deferred revenue 11.86M - 77.32M 32.61M 27.22M
Net debt 190.78M 170.88M 124.04M 92.03M 69.36M
Short term debt 11.17M 9.75M 7.99M 6.33M 7.13M
Short long term debt total 199.62M 180.31M 135.37M 100.04M 77.23M
Other stockholder equity - - -0.00M -409.41M -404.71M
Property plant equipment - - - 109.39M 95.06M
Total current assets 44.12M 41.68M 55.78M 29.94M 25.64M
Long term investments - - - 1.28M 1.05M
Net tangible assets - - - -7.25M 9.02M
Short term investments - - - 0.30M -
Net receivables 17.62M 7.91M 30.59M 10.53M 8.45M
Long term debt - - - 38.87M 9.76M
Inventory 10.37M 9.00M 8.18M 6.43M 5.25M
Accounts payable 5.05M 5.78M 3.08M 1.85M 3.34M
Accumulated other comprehensive income -94.89M -143.37M -102.15M -70.85M -76.13M
Non currrent assets other - 6.32M 23.97M 0.47M -355.00M
Non current assets total 468.23M 450.92M 452.69M 391.96M 355.17M
Capital lease obligations - - - 61.17M 67.47M
Long term debt total - - - 93.71M 70.10M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -38.80M -40.51M -15.16M
Change to liabilities - - - 1.96M 0.68M
Total cashflows from investing activities -23.77M -17.43M -38.80M -40.51M -15.16M
Net borrowings - - 21.00M 19.82M -0.26M
Total cash from financing activities -6.85M 2.67M -10.39M 1.51M -17.63M
Change to operating activities - - - 1.15M 0.35M
Net income 7.42M 25.01M -6.53M 21.84M 18.41M
Change in cash -0.58M -1.91M 3.33M 0.13M -0.89M
Begin period cash flow 9.43M 11.33M 8.01M 7.87M 8.76M
End period cash flow 8.84M 9.43M 11.33M 8.01M 7.87M
Total cash from operating activities 30.20M 12.90M 52.52M 39.12M 31.89M
Depreciation 23.35M 22.34M 18.58M 12.88M 12.35M
Other cashflows from investing activities - -1.96M -0.85M -12.72M -3.40M
Dividends paid 4.68M -19.87M -18.32M 17.14M 16.75M
Change to inventory -1.37M -0.82M -1.75M -1.18M -1.04M
Change to account receivables -0.58M 15.44M -20.57M -2.98M -2.70M
Other cashflows from financing activities -13.18M -4.02M -13.07M 31.65M 17.25M
Change to netincome - - - 3.13M 4.07M
Capital expenditures 22.93M 12.43M 20.82M 27.79M 11.76M
Change in working capital -1.47M 15.60M -21.00M -4.16M -3.74M
Stock based compensation - 0.77M 0.32M 0.32M 0.25M
Other non cash items 0.90M -50.82M 61.46M 4.40M 1.13M
Free cash flow 7.27M 0.47M 31.70M 11.33M 20.13M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MVF
Monash Ivf Group Ltd
-
-%
0.74 37.00 16.21 1.07 1.17 1.79 11.73
SHL
Sonic Healthcare Ltd
0.18
0.91%
20.06 16.16 17.21 0.90 1.15 1.36 8.10
IDX
Integral Diagnostics Ltd
0.01
0.58%
1.74 28.83 15.24 0.82 0.97 1.52 9.49
ACL
Australian Clinical Labs Ltd
0.04
1.25%
3.24 26.67 16.84 0.81 3.95 1.24 5.12
HLS
Healius Ltd
0.01
1.01%
0.50 - 29.24 0.26 2.08 0.94 10.14

Profile*

Monash Ivf Group Ltd

Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.

510 Church Street, Cremorne, VIC, Australia, 3121

61 3 9420 8235

892

Name Title Year Born
Mr. Michael D. Knaap CEO, MD & Exec. Director NA
Mr. Malik Jainudeen Group CFO & Company Sec. NA
Dr. Hamish Hamilton Chief Operating Officer NA
Dr. Richard Charles Henshaw M.D. Exec. Director NA
Dr. Deirdre Zander-Fox BSc. (Hons.), Dip. of Mgt, Ph.D. Chief Scientific Officer NA
Mr. Thierry Panthier Chief Information Officer NA
Ms. Fiona Allen Chief Marketing Officer NA
Ms. Peggy North Chief People & Culture Officer NA
Ms. Tedd Fuell Chief Governance & Risk Officer NA
Ms. Clementina Singh Gen. Mang. of New South Wales NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…